Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Safety and Efficacy of Ultrasound-Guided Focused Ultrasound for Palliation of Bone Metastases

EF 2014-15

Résumé
Cancer commonly metastasizes to bones. Up to 75% of patients with bone metastases experience significant pain that reduces their quality of life (QOL). The standard treatment for painful bone metastases is radiotherapy, however, 40% of patients do not respond to radiotherapy, some reach the limit of radiotherapy, while other patients can experience pain relapse following treatment. Therefore another treatment option is necessary. Focused ultrasound (FUS) is a non-invasive treatment that uses beams of concentrated ultrasound to heat targeted tissue. For bone metastases, it is believed that pain relief from FUS treatment is due to heat-induced nerve damage or tumour tissue death. Image guidance is required to visualize the targeted location for treatment. For painful bone metastases, magnetic resonance imaging (MRI)-guided FUS have previously been shown to be safe and efficacious however it is limited due to the need of a large, immobile MRI machine. To improve accessibility, ultrasound is another imaging technique that may be used. Therefore ultrasound-guided FUS may be a portable, handheld treatment for painful bone metastases and its safety and efficacy will be tested in this proposed study. A total of 20 patients with bone metastases will be recruited for this study. These patients will be treated with ultrasound-guided FUS under anesthesia and followed for 42 days after treatment. Treatment efficacy, safety and patient's quality of life will be assessed prior to and after treatment using validated questionnaires. This study is the first in proposing its usage in patients with painful bone metastases and has the potential to significantly improve the QOL of many patients that require palliation of painful bone metastases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331401
Name
Wong Erin (Nga Lam)
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Safety and Efficacy of Ultrasound-Guided Focused Ultrasound for Palliation of Bone Metastases
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bone Metastases; Cancer; Focused Ultrasound; Image-Guided Therapy; Pain; Palliation; Quality Of Life; Safety; Ultrasound
Abstract
Cancer commonly metastasizes to bones. Up to 75% of patients with bone metastases experience significant pain that reduces their quality of life (QOL). The standard treatment for painful bone metastases is radiotherapy, however, 40% of patients do not respond to radiotherapy, some reach the limit of radiotherapy, while other patients can experience pain relapse following treatment. Therefore another treatment option is necessary. Focused ultrasound (FUS) is a non-invasive treatment that uses beams of concentrated ultrasound to heat targeted tissue. For bone metastases, it is believed that pain relief from FUS treatment is due to heat-induced nerve damage or tumour tissue death. Image guidance is required to visualize the targeted location for treatment. For painful bone metastases, magnetic resonance imaging (MRI)-guided FUS have previously been shown to be safe and efficacious however it is limited due to the need of a large, immobile MRI machine. To improve accessibility, ultrasound is another imaging technique that may be used. Therefore ultrasound-guided FUS may be a portable, handheld treatment for painful bone metastases and its safety and efficacy will be tested in this proposed study. A total of 20 patients with bone metastases will be recruited for this study. These patients will be treated with ultrasound-guided FUS under anesthesia and followed for 42 days after treatment. Treatment efficacy, safety and patient's quality of life will be assessed prior to and after treatment using validated questionnaires. This study is the first in proposing its usage in patients with painful bone metastases and has the potential to significantly improve the QOL of many patients that require palliation of painful bone metastases.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wong, Erin (Nga Lam)
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~